Upcoming Presentations


Date
Presentation
Webcast
Registration
19th March 2024
Results of LEGEND Phase IIa combination trial with lanifibranor and empagliflozin in patients with MASH/NASH and T2D

Latest Presentations


Date
Presentation
Webcast
Registration
6th March 2024
TD Cowen 44th Annual Health Care Conference
15th November 2023
Stifel Healthcare Conference

Investor Contacts


Inventiva
50 rue de Dijon
21121 Daix, France
Email: finance@inventivapharma.com
Tel: +33 (0)3 80 44 75 00

Patti Bank
Managing Director
ICR Westwicke
Patti.Bank@westwicke.com
D 415-513-1284
San Francisco, CA
www.westwicke.com